Purchases and Sales Made in Q4 2023 in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA) during Q4 2023. The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-215K- 10.5% |
$4.98M - $6.96M
|
1.83M
$23.4M
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-546K- 17.66% |
$12.6M - $17.7M
|
2.55M
$32.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-711K- 36.08% |
$16.5M - $23M
|
1.26M
$16.1M
|